Compass Therapeutics Overview

  • Founded
  • 2014

Founded
  • Status
  • Public

  • Employees
  • 24

Employees
  • Stock Symbol
  • CMPX

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $2.80

  • (As of Friday Closing)

Compass Therapeutics General Information

Description

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases.

Contact Information

Formerly Known As
Kairos Biologics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 80 Guest Street
  • Suite 601
  • Boston, MA 02135
  • United States

Compass Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Compass Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.80 $2.70 $1.25 - $5.80 $273M 101M 196K -$1.29

Compass Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV (1,692) 293,396
Revenue 0 0 0 0
EBITDA (80,082) (80,216) (26,244) (32,048)
Net Income (81,922) (82,181) (29,500) (34,744)
Total Assets 146,564 153,757 51,911 30,381
Total Debt 3,767 4,037 9,334 14,869
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Compass Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Compass Therapeutics‘s full profile, request access.

Request a free trial

Compass Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics i
Drug Discovery
Boston, MA
24 As of 2021
00000
00000000 00000

000000

uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pa
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000

000000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Compass Therapeutics Competitors (105)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corvus Pharmaceuticals Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 000000000000 00000
You’re viewing 5 of 105 competitors. Get the full list »

Compass Therapeutics Patents

Compass Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3127072-A1 Formulations of antibodies that bind human cd137 and uses thereof Pending 16-Jan-2019 00000000000
AU-2020208397-A1 Formulations of antibodies that bind human cd137 and uses thereof Pending 16-Jan-2019 00000000000
EP-3911679-A1 Formulations of antibodies that bind human cd137 and uses thereof Pending 16-Jan-2019 00000000000
EP-3897117-A1 Transgenic mouse expressing common human light chain Pending 21-Dec-2018 00000000000
AU-2019379576-A1 Multispecific binding constructs against checkpoint molecules and uses thereof Pending 13-Nov-2018 C07K16/2818
To view Compass Therapeutics’s complete patent history, request access »

Compass Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Thomas Schuetz Ph.D Chief Executive Officer & Board Member
Vered Bisker-Leib Ph.D Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Susan Kalled Ph.D Chief Scientific Officer
Neil Lerner Vice President, Finance
You’re viewing 4 of 13 executive team members. Get the full list »

Compass Therapeutics Board Members (17)

Name Representing Role Since
Bruce Steel Self Board Observer 000 0000
Carl Gordon Ph.D Self Chairman & Board Member 000 0000
Miranda Toledano Self Board Member 000 0000
Philip Ferneau JD Borealis Ventures Board Member 000 0000
Stephen Squinto Ph.D Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Compass Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Compass Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Compass Therapeutics‘s full profile, request access.

Request a free trial

Compass Therapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 25-Jun-2021 0000000000 000.00 Drug Discovery 000000 00
Olivia Ventures 23-Jun-2020 Merger/Acquisition Other Capital Markets/Institutions 000000 00
To view Compass Therapeutics’s complete acquisitions history, request access »

Compass Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Drug Discovery Irvine, CA 0000
To view Compass Therapeutics’s complete subsidiaries history, request access »